Cargando…
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions
Assessment of pharmacodynamic (PD) drug interactions is a cornerstone of the development of combination drug therapies. To guide this venture, we derive a general pharmacodynamic interaction (GPDI) model for ≥2 interacting drugs that is compatible with common additivity criteria. We propose a PD int...
Autores principales: | Wicha, Sebastian G., Chen, Chunli, Clewe, Oskar, Simonsson, Ulrika S. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730559/ https://www.ncbi.nlm.nih.gov/pubmed/29242552 http://dx.doi.org/10.1038/s41467-017-01929-y |
Ejemplares similares
-
A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations
por: Clewe, Oskar, et al.
Publicado: (2018) -
Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models
por: Chen, Chunli, et al.
Publicado: (2017) -
Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distribution
por: Clewe, Oskar, et al.
Publicado: (2015) -
A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis
por: Clewe, Oskar, et al.
Publicado: (2020) -
A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro
por: Clewe, Oskar, et al.
Publicado: (2016)